Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


EGFR inhibitor
BML-EI386-0005 5 mg 212.00 USD
Do you need bulk/larger quantities?
DAPH abolishes or greatly reduces previously existing fully formed β-amyloid (1-42) fibrils and eliminates β-amyloid (1-42) peptide neurotoxicity. Also inhibits EGFR kinase. IC50 for inhibition of β-sheet content of aggregated β-amyloid (1-42) is 4.5µM.

Product Details

Alternative Name:4,5-Dianilinophthalimide, CGP-52411
Purity:≥98% (HPLC)
Identity:Determined by 1H-NMR and MS.
Appearance:Orange solid.
Solubility:Soluble in DMSO (25mg/ml).
Shipping:Blue Ice
Long Term Storage:-20°C
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs: H. Wang, et al.; Proc. Natl. Acad. Sci. USA 105, 7159 (2008), Abstract; Full Text
Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule: B. J. Blanchard, et al.; Proc. Natl. Acad. Sci. USA 101, 14326 (2004), Abstract; Full Text
Transforming growth factor-alpha acting at the epidermal growth factor receptor reduces infarct volume after permanent middle cerebral artery occlusion in rats: C. Justicia & A. M. Planas; J. Cereb. Blood Flow. Metab. 19, 128 (1999), Abstract;

Related Literature

Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces